Denga

Denga is a healthtech company dedicated to improving the diagnosis and management of dengue fever in Africa. Supported by the Novartis Foundation, Denga utilizes cutting-edge digital tools to strengthen disease surveillance and streamline patient care processes. By enabling faster and more accurate detection of dengue fever, Denga helps healthcare providers deliver timely treatment, ultimately mitigating the severity and spread of outbreaks. Their technology-driven approach addresses critical gaps in healthcare infrastructure, promoting better health outcomes in dengue-affected communities. Targeting healthcare systems and providers across Africa, Denga’s solutions are designed to support resource-limited settings where dengue fever poses a significant public health challenge. Through enhanced monitoring and management, Denga contributes to reducing the burden of dengue and improving disease control across the continent.